$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

$amn Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000114275020000044 Filed on November 06, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$631.3M	$551.6M	$567.6M
YoY Change	7.56%	-2.81%	7.74%
Cost Of Revenue	$423.7M	$367.0M	$377.6M
YoY Change	8.7%	-2.8%	7.36%
Gross Profit	$207.5M	$184.6M	$190.0M
YoY Change	5.28%	-2.84%	8.5%
Gross Profit Margin	32.88%	33.47%	33.48%
Selling, General & Admin	$124.2M	$111.2M	$133.2M
YoY Change	-6.76%	-16.49%	9.89%
% of Gross Profit	59.84%	60.25%	70.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$24.10M	$27.40M	$17.09M
YoY Change	41.76%	60.37%	51.25%
% of Gross Profit	11.61%	14.84%	8.99%
Operating Expenses	$147.9M	$138.2M	$150.3M
YoY Change	-1.47%	-8.06%	13.42%
Operating Profit	$59.64M	$46.46M	$39.74M
YoY Change	26.8%	16.92%	-6.79%
Interest Expense	-$22.70M	$12.56M	$7.830M
YoY Change	155.06%	60.46%	68.42%
% of Operating Profit	-38.06%	27.04%	19.7%
Other Income/Expense, Net	-$16.10M
YoY Change	-47.23%
Pretax Income	$6.000M	$33.90M	$31.91M
YoY Change	-84.25%	6.23%	-16.0%
Income Tax	-$3.300M	$7.831M	$8.394M
% Of Pretax Income	-55.0%	23.1%	26.31%
Net Earnings	$9.308M	$26.07M	$23.52M
YoY Change	-66.13%	10.85%	-15.77%
Net Earnings / Revenue	1.47%	4.73%	4.14%
Basic Earnings Per Share	$0.20	$0.55	$0.50
Diluted Earnings Per Share	$0.19	$0.55	$0.49
COMMON SHARES
Basic Shares Outstanding	47.03M shares	47.48M shares	46.68M shares
Diluted Shares Outstanding		47.68M shares	47.61M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.20M	$58.40M	$40.70M
YoY Change	-64.82%	43.49%	118.82%
Cash & Equivalents	$29.21M	$58.42M	$40.75M
Short-Term Investments	$868.0M
Other Short-Term Assets	$40.81M	$30.59M	$37.37M
YoY Change	0.9%	-18.13%	5.68%
Inventory	$3.382B
Prepaid Expenses	$13.63M	$15.65M	$11.33M
Receivables	$376.1M	$352.7M	$354.7M
Other Receivables	$6.600M	$0.00	$4.200M
Total Short-Term Assets	$533.7M	$513.7M	$506.9M
YoY Change	-4.78%	1.34%	5.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$116.2M	$112.8M	$100.2M
YoY Change	10.82%	12.53%	15.41%
Goodwill	$864.5M	$869.9M	$586.6M
YoY Change	45.16%	48.3%	33.84%
Intangibles	$564.9M	$580.7M	$400.4M
YoY Change	41.77%	45.01%	20.33%
Long-Term Investments	$1.944B
YoY Change	-5.14%
Other Assets	$135.1M	$125.8M	$115.5M
YoY Change	12.36%	8.96%	23.9%
Total Long-Term Assets	$1.820B	$1.831B	$1.354B
YoY Change	32.72%	35.23%	34.0%
TOTAL ASSETS
Total Short-Term Assets	$533.7M	$513.7M	$506.9M
Total Long-Term Assets	$1.820B	$1.831B	$1.354B
Total Assets	$2.354B	$2.345B	$1.861B
YoY Change	21.84%	26.0%	24.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$167.9M	$152.9M	$139.5M
YoY Change	7.52%	9.63%	-2.13%
Accrued Expenses	$37.85M	$44.24M	$35.13M
YoY Change	4.14%	25.95%	-7.08%
Deferred Revenue	$11.00M	$11.90M	$11.23M
YoY Change	-6.65%	5.99%	-14.34%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.688M	$9.400M	$3.800M
YoY Change		147.37%
Total Short-Term Liabilities	$423.0M	$386.2M	$343.9M
YoY Change	11.86%	12.29%	13.47%
LONG-TERM LIABILITIES
Long-Term Debt	$858.0M	$894.5M	$611.9M
YoY Change	39.01%	46.18%	30.08%
Other Long-Term Liabilities	$107.9M	$95.74M	$59.66M
YoY Change	74.57%	60.48%	-23.05%
Total Long-Term Liabilities	$107.9M	$95.74M	$59.66M
YoY Change	74.57%	60.48%	-23.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$423.0M	$386.2M	$343.9M
Total Long-Term Liabilities	$107.9M	$95.74M	$59.66M
Total Liabilities	$1.534B	$1.538B	$1.156B
YoY Change	28.36%	33.03%	32.01%
SHAREHOLDERS EQUITY
Retained Earnings	$469.6M	$460.3M	$372.6M
YoY Change	17.38%	23.54%	48.76%
Common Stock	$496.0K	$495.0K	$493.0K
YoY Change	0.61%	0.41%	1.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$119.1M	$119.1M	$119.1M
YoY Change	0.0%	0.0%	38.26%
Treasury Stock Shares	2.561M shares	2.561M shares	2.561M shares
Shareholders Equity	$819.7M	$807.1M	$705.1M
YoY Change
Total Liabilities & Shareholders Equity	$2.354B	$2.345B	$1.861B
YoY Change	21.84%	26.0%	24.87%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	$9.308M	$26.07M	$23.52M
YoY Change	-66.13%	10.85%	-15.77%
Depreciation, Depletion And Amortization	$24.10M	$27.40M	$17.09M
YoY Change	41.76%	60.37%	51.25%
Cash From Operating Activities	$39.80M	$88.70M	$80.90M
YoY Change	-49.43%	9.64%	92.16%
INVESTING ACTIVITIES
Capital Expenditures	-$10.30M	-$7.700M	-$9.200M
YoY Change	-2.83%	-16.3%	22.67%
Acquisitions
YoY Change
Other Investing Activities	$600.0K	-$7.600M	-$3.700M
YoY Change	-102.17%	105.41%	-85.32%
Cash From Investing Activities	-$9.700M	-$15.20M	-$12.90M
YoY Change	-74.61%	17.83%	-60.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-55.10M	-62.40M	-52.90M
YoY Change	-27650.0%	17.96%	43.36%
NET CHANGE
Cash From Operating Activities	39.80M	88.70M	80.90M
Cash From Investing Activities	-9.700M	-15.20M	-12.90M
Cash From Financing Activities	-55.10M	-62.40M	-52.90M
Net Change In Cash	-25.00M	11.10M	15.10M
YoY Change	-161.43%	-26.49%	-155.11%
FREE CASH FLOW
Cash From Operating Activities	$39.80M	$88.70M	$80.90M
Capital Expenditures	-$10.30M	-$7.700M	-$9.200M
Free Cash Flow	$50.10M	$96.40M	$90.10M
YoY Change	-43.9%	6.99%	81.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001142750
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2018	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201613Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-16753
	dei	Entity Registrant Name EntityRegistrantName	AMN HEALTHCARE SERVICES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1500476
	dei	Entity Address Address Line1 EntityAddressAddressLine1	8840 Cypress Waters Boulevard
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75019
	dei	City Area Code CityAreaCode	866
	dei	Local Phone Number LocalPhoneNumber	871-8519
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	AMN
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47030832	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58419000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82985000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8511000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3332000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	352746000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	352685000	USD
CY2020Q3	amn	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	56300000	USD
CY2019Q4	amn	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	72714000	USD
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15647000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11669000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	30591000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40446000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	513703000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	560499000	USD
CY2020Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	60898000	USD
CY2019Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	62170000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	153390000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132900000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112752000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104832000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	81082000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89866000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	125831000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	120254000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	869941000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	595551000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	199488000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	151417000	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	580658000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	398474000	USD
CY2020Q3	us-gaap	Assets Assets	2344865000	USD
CY2019Q4	us-gaap	Assets Assets	1931646000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	152935000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	156140000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	184736000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	170932000	USD
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9375000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15338000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13943000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11900000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11788000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11884000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25302000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	386168000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	378105000	USD
CY2020Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	40000000	USD
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2020Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	854533000	USD
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	617159000	USD
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	79681000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	46618000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	81674000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	91209000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	95736000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61813000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	1537792000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1194904000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49550000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46989000	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49283000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46722000	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	495000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	493000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	465438000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	455193000	USD
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2561000	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2561000	shares
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	119143000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	119143000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	460250000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	400047000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	33000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	152000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	807073000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	736742000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2344865000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1931646000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	551631000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	567597000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1762443000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1635215000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	366998000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	377566000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1178204000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1088883000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	184633000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	190031000	USD
	us-gaap	Gross Profit GrossProfit	584239000	USD
	us-gaap	Gross Profit GrossProfit	546332000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	111235000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	133207000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	394537000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	374872000	USD
CY2020Q3	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	26936000	USD
CY2019Q3	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	17085000	USD
	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	69096000	USD
	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	41513000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	138171000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	150292000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	39739000	USD
	us-gaap	Operating Expenses OperatingExpenses	463633000	USD
	us-gaap	Operating Expenses OperatingExpenses	416385000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	46462000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	120606000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	129947000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	12564000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	7830000	USD
	us-gaap	Interest Expense InterestExpense	35061000	USD
	us-gaap	Interest Expense InterestExpense	19568000	USD
CY2020Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	33898000	USD
CY2019Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	31909000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	85545000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	110379000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7831000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8394000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24188000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23873000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	26067000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	23515000	USD
	us-gaap	Net Income Loss NetIncomeLoss	61357000	USD
	us-gaap	Net Income Loss NetIncomeLoss	86506000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-14000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	132000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-119000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-58000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	132000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-119000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-58000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26053000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23647000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	61238000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	86448000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.82
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47476000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46677000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47406000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46701000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47676000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47607000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47647000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47600000	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	638990000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	17930000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-10281000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5186000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34021000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	649986000	USD
CY2019Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	775000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1253000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3702000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	28780000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	680440000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1808000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2825000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23647000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	705104000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	736742000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-4353000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4927000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12918000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	749080000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-288000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6347000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22267000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	777406000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-158000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3772000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	26053000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	807073000	USD
	us-gaap	Net Income Loss NetIncomeLoss	61357000	USD
	us-gaap	Net Income Loss NetIncomeLoss	86506000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	70077000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41513000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	3727000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1816000	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	1773000	USD
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1700000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2283000	USD
	amn	Accounts Receivable And Sales Credits Credit Loss Expense Reversal AccountsReceivableAndSalesCreditsCreditLossExpenseReversal	7580000	USD
	amn	Accounts Receivable And Sales Credits Credit Loss Expense Reversal AccountsReceivableAndSalesCreditsCreditLossExpenseReversal	6809000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17923000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3700000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15046000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11713000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-3664000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-449000	USD
	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	96000	USD
	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	276000	USD
	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	-798000	USD
	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	0	USD
	amn	Lessee Operating Lease Noncash Expense LesseeOperatingLeaseNoncashExpense	-244000	USD
	amn	Lessee Operating Lease Noncash Expense LesseeOperatingLeaseNoncashExpense	1000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15151000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25146000	USD
	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	-16414000	USD
	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	12610000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6157000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	3401000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3361000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1118000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2977000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1332000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3378000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	8790000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5484000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14277000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7630000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	19787000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	29592000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-7273000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-32000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2038000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-12000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-99000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	216981000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	146205000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27357000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24776000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	37418000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	16759000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	21500000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	28635000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	7171000	USD
	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	490000	USD
	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	11364000	USD
	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	303000	USD
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	476491000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	228222000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1400000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1120000	USD
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	66000	USD
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-528458000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-253606000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	203125000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	938000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	150000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18705000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	205000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	245000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	101000000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	202000000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6898000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	875000	USD
	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	10622000	USD
	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	5700000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4798000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13342000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	266557000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136440000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-119000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-58000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-45039000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28981000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84324000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108923000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113305000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	15079000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	13294000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	300000	USD
	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	363000	USD
	us-gaap	Interest Paid Net InterestPaidNet	13848000	USD
	us-gaap	Interest Paid Net InterestPaidNet	14988000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30727000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	32457000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	35704000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	28542000	USD
	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	274427000	USD
	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	148095000	USD
	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	228000000	USD
	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	98580000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	61640000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	34873000	USD
	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	USD
	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	12122000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	476491000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	228222000	USD
	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	1007000	USD
	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	2142000	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	BASIS OF PRESENTATION<div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheets and related condensed consolidated statements of comprehensive income and cash flows contained in this Quarterly Report on Form 10-Q (this “Quarterly Report”), which are unaudited, include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all entries necessary for a fair presentation of such unaudited condensed consolidated financial statements have been included. These entries consisted of all normal recurring items. The results of operations for the interim period are not necessarily indicative of the results to be expected for any other interim period or for the entire fiscal year or for any future period.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements do not include all information and notes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). Please refer to the Company’s audited consolidated financial statements and the related notes for the fiscal year ended December 31, 2019, contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed with the Securities and Exchange Commission on February 25, 2020 (“2019 Annual Report”). </span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coronavirus Pandemic</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2020, the World Health Organization declared the outbreak of a novel strain of coronavirus, also known as COVID-19, a global pandemic. Due to the pandemic, there has been uncertainty and disruption in the global economy and significant volatility of financial markets. The Company is closely monitoring the impact of the pandemic, which continues to evolve, and its effects and risks on our operations, liquidity, financial condition and financial results for the full year 2020 and, possibly, beyond. The Company also implemented remote-work arrangements effective mid-March 2020 and, to date, transitioning to a remote-work environment has not had a material adverse impact on the Company’s ability to continue to operate its business, financial reporting process or internal controls and procedures.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates used for, but not limited to, determining the collectability of accounts receivable, fair value of long-lived assets, and goodwill could be impacted by the pandemic. While the full impact of COVID-19, including the duration and severity of the pandemic, remains unknown, the Company has made appropriate estimates based on the facts and circumstances available as of the reporting date. Specifically, the Company continues to monitor the impacts of the pandemic on its customers’ liquidity and capital resources and, therefore, the Company’s ability to collect, or the timeliness of collection of accounts receivable. The impact of COVID-19 did not have a material effect on the Company’s estimates as of September 30, 2020. These estimates may change as new events occur and additional information is obtained. See additional information below regarding the allowance for credit losses for accounts receivable.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016-13, “Measurement of Credit Losses on Financial Instruments.” The FASB also issued a series of other ASUs, which update ASU 2016-13 (collectively, the “credit loss standard”). This new standard introduces new accounting models for determining and recognizing credit losses on certain financial instruments based on an estimate of current expected credit losses. The Company adopted this standard effective January 1, 2020 using the modified retrospective transition method. The Company recognized the cumulative effect of adopting this guidance as an adjustment to the opening balance of retained earnings of $1,154, net of tax, primarily related to its allowance for credit losses for accounts receivable. Prior period amounts are not retrospectively adjusted. The impact of the adoption of the new standard was not material to the Company’s condensed consolidated financial statements for the three and nine months ended September 30, 2020. The Company expects the impact to </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be immaterial on an ongoing basis. See additional information below regarding the allowance for credit losses for accounts receivable.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, “Simplifying the Test for Goodwill Impairment.” The standard simplifies the subsequent measurement of goodwill by removing the requirement to perform a hypothetical purchase price allocation to compute the implied fair value of goodwill to measure impairment. Instead, any goodwill impairment will equal the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. Further, the guidance eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. The Company adopted this standard effective January 1, 2020 and the adoption did not have a material effect on the Company’s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, “Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement.” The standard modifies the current disclosure requirements on fair value measurements. The Company adopted this standard effective January 1, 2020. Refer to information regarding fair value measurements in Note (7), “Fair Value Measurement.”</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments. Restricted cash and cash equivalents primarily represent cash and money market funds on deposit with financial institutions and investments represents commercial paper that serves as collateral for the Company’s outstanding letters of credit and captive insurance subsidiary claim payments. See Note (7), “Fair Value Measurement” for additional information.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying condensed consolidated balance sheets and related notes to the amounts presented in the accompanying condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,419 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,985 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash and cash equivalents (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,194 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,393 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,898 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash and investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,511 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,548 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less restricted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,586)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,923 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,962 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for expected credit losses based on the Company’s historical write-off experience, an assessment of its customers’ financial conditions and available information that is relevant to assessing the collectability of cash flows, which includes current conditions and forecasts about future economic conditions.</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of activity in the allowance for credit losses for accounts receivable:</span></div><div style="margin-bottom:5pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1,</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjcyNDBjNTRiMDE0NzQ1N2ZhYWMxODhlMWM1MzA1NTgyL3NlYzo3MjQwYzU0YjAxNDc0NTdmYWFjMTg4ZTFjNTMwNTU4Ml8zMS9mcmFnOjhjNTFlZDdhZmM2ZDRlOTNhMTVkMTg2ZmNmMTA5ZmUxL3RhYmxlOjQ1MTk4NzJkODc4NDRhZGE5ZmVjNmJkNzM1MDU5NmFiL3RhYmxlcmFuZ2U6NDUxOTg3MmQ4Nzg0NGFkYTlmZWM2YmQ3MzUwNTk2YWJfMi0wLTEtMS0w_d67948c3-ec43-4d67-8cc0-c9df96f914b6">Adoption of the credit loss standard, cumulative-effect adjustment to retained earnings</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for expected credit losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,178 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts written off charged against the allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of September 30,</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,511 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reclassified its allowance for accounts receivable in the prior year’s consolidated balance sheet to conform to the current year presentation. The prior year’s balance of accounts receivable (net of allowances) remains unchanged.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to intangible assets purchased in a business combination, asset impairments, accruals for self-insurance, compensation and related benefits, accounts receivable, contingencies and litigation, earn-out liabilities, and income taxes. Actual results could differ from those estimates under different assumptions or conditions.
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58419000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	82985000	USD
CY2019Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	62170000	USD
CY2020Q3	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	134511000	USD
CY2019Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	163548000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	15194000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18393000	USD
CY2020Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	60898000	USD
CY2020Q3	us-gaap	Restricted Investments RestrictedInvestments	25588000	USD
CY2019Q4	us-gaap	Restricted Investments RestrictedInvestments	9586000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	108923000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	11408000	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reclassified its allowance for accounts receivable in the prior year’s consolidated balance sheet to conform to the current year presentation. The prior year’s balance of accounts receivable (net of allowances) remains unchanged.</span></div>
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3332000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5178000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1333000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	8511000	USD
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	4	acquisition
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9498000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	26067000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	23515000	USD
	us-gaap	Net Income Loss NetIncomeLoss	61357000	USD
	us-gaap	Net Income Loss NetIncomeLoss	86506000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.85
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.82
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47476000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46677000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47406000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46701000	shares
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	200000	shares
CY2019Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	930000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	241000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	899000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47676000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47607000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47647000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47600000	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	84000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	79000	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32000	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	15046000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	55000	shares
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q3	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	26936000	USD
CY2019Q3	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	17085000	USD
	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	69096000	USD
	amn	Depreciation Depletion And Amortization Not Included In Cost Of Revenue DepreciationDepletionAndAmortizationNotIncludedInCostOfRevenue	41513000	USD
CY2020Q3	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	481000	USD
CY2019Q3	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	0	USD
	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	981000	USD
	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	0	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	3772000	USD
CY2019Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2825000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11713000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	12564000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	7830000	USD
	us-gaap	Interest Expense InterestExpense	35061000	USD
	us-gaap	Interest Expense InterestExpense	19568000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	33898000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	31909000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	85545000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	110379000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	551631000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	567597000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1762443000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1635215000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	595551000	USD
	amn	Goodwill Change In Goodwill Allocation GoodwillChangeInGoodwillAllocation	0	USD
CY2020Q3	us-gaap	Goodwill Goodwill	869941000	USD
CY2020Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	USD
CY2019Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	15194000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18393000	USD
CY2020Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	5984000	USD
CY2020Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	15397000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	16069000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	30591000	USD
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40446000	USD
CY2020Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	45807000	USD
CY2019Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	37315000	USD
CY2020Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	210735000	USD
CY2019Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	191050000	USD
CY2020Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	9600000	USD
CY2019Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	9367000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	266142000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	237732000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	153390000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	132900000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112752000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104832000	USD
CY2020Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	87485000	USD
CY2019Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	79515000	USD
CY2020Q3	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	38346000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	44240000	USD
CY2019Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	40739000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	125831000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	120254000	USD
CY2020Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	29331000	USD
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	26985000	USD
CY2020Q3	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	59753000	USD
CY2019Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	75562000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36344000	USD
CY2020Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	7302000	USD
CY2019Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	6146000	USD
CY2020Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	9104000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7925000	USD
CY2020Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3205000	USD
CY2019Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3178000	USD
CY2020Q3	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	152935000	USD
CY2019Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	156140000	USD
CY2020Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	51016000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47381000	USD
CY2020Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	27833000	USD
CY2019Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	22613000	USD
CY2020Q3	amn	Accrued Travel Expense AccruedTravelExpense	1796000	USD
CY2019Q4	amn	Accrued Travel Expense AccruedTravelExpense	2459000	USD
CY2020Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5537000	USD
CY2019Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	4019000	USD
CY2020Q3	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	9554000	USD
CY2019Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	8782000	USD
CY2020Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	87934000	USD
CY2019Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	81064000	USD
CY2020Q3	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1066000	USD
CY2019Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	4614000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	184736000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61813000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	170932000	USD
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1400000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	20000000	USD
CY2020Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	10484000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	5302000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11884000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	25302000	USD
CY2020Q3	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	19711000	USD
CY2019Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	18291000	USD
CY2020Q3	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	33642000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	34606000	USD
CY2020Q3	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	5751000	USD
CY2019Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	5431000	USD
CY2020Q3	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	36632000	USD
CY2019Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	3485000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	95736000	USD

Files In Submission

Name	View Source	Status
0001142750-20-000044-index-headers.html	Edgar Link	pending
0001142750-20-000044-index.html	Edgar Link	pending
0001142750-20-000044.txt	Edgar Link	pending
0001142750-20-000044-xbrl.zip	Edgar Link	pending
amn-20200930.htm	Edgar Link	pending
amn-20200930.xsd	Edgar Link	pending
amn-20200930_cal.xml	Edgar Link	unprocessable
amn-20200930_def.xml	Edgar Link	unprocessable
amn-20200930_g1.jpg	Edgar Link	pending
amn-20200930_htm.xml	Edgar Link	completed
amn-20200930_lab.xml	Edgar Link	unprocessable
amn-20200930_pre.xml	Edgar Link	unprocessable
amn-ex311x20200930x10q.htm	Edgar Link	pending
amn-ex312x20200930x10q.htm	Edgar Link	pending
amn-ex321x20200930x10q.htm	Edgar Link	pending
amn-ex322x20200930x10q.htm	Edgar Link	pending
amn-ex41x20200930x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

2020 Q4 Form 10-Q Financial Statement

#000114275020000044 Filed on November 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN AMN HEALTHCARE SERVICES INC Stock $amn

2020 Q4 Form 10-Q Financial Statement

#000114275020000044 Filed on November 06, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn